| Primary |
| Renal Transplant |
48.3% |
| Liver Transplant |
11.6% |
| Immunosuppression |
8.9% |
| Heart Transplant |
4.5% |
| Renal And Pancreas Transplant |
4.5% |
| Lung Transplant |
3.1% |
| Antiviral Prophylaxis |
3.0% |
| Immunosuppressant Drug Therapy |
2.6% |
| Liver And Small Intestine Transplant |
2.5% |
| Prophylaxis |
2.0% |
| Small Intestine Transplant |
1.5% |
| Antifungal Prophylaxis |
1.3% |
| Hypertension |
1.2% |
| Transplant |
1.2% |
| Graft Versus Host Disease |
1.0% |
| Renal And Liver Transplant |
0.8% |
| Prophylaxis Against Transplant Rejection |
0.7% |
| Acute Graft Versus Host Disease |
0.5% |
| Antibiotic Prophylaxis |
0.5% |
| Pancreas Transplant |
0.5% |
|
| Respiratory Failure |
10.4% |
| Cytomegalovirus Infection |
9.0% |
| Residual Urine |
9.0% |
| Kidney Transplant Rejection |
7.5% |
| Death |
6.0% |
| Pyrexia |
6.0% |
| Tubulointerstitial Nephritis |
6.0% |
| Capillaritis |
4.5% |
| Sepsis |
4.5% |
| Thrombotic Microangiopathy |
4.5% |
| Urinary Tract Infection |
4.5% |
| White Blood Cell Count Increased |
4.5% |
| Biliary Ischaemia |
3.0% |
| Blood Creatinine Increased |
3.0% |
| Complications Of Transplanted Kidney |
3.0% |
| Drug Ineffective |
3.0% |
| Liver Function Test Abnormal |
3.0% |
| Lung Infection |
3.0% |
| Pain In Extremity |
3.0% |
| Pleural Effusion |
3.0% |
|
| Secondary |
| Renal Transplant |
37.0% |
| Immunosuppression |
14.2% |
| Prophylaxis Against Transplant Rejection |
9.7% |
| Prophylaxis |
6.7% |
| Immunosuppressant Drug Therapy |
6.6% |
| Liver Transplant |
6.5% |
| Drug Use For Unknown Indication |
3.7% |
| Transplant |
2.1% |
| Product Used For Unknown Indication |
2.0% |
| Stem Cell Transplant |
1.6% |
| Hypertension |
1.5% |
| Lung Transplant |
1.5% |
| Transplant Rejection |
1.3% |
| Heart Transplant |
1.1% |
| Pain Prophylaxis |
1.0% |
| Renal And Pancreas Transplant |
0.8% |
| Small Intestine Transplant |
0.7% |
| Antifungal Prophylaxis |
0.7% |
| Antiviral Prophylaxis |
0.6% |
| Premedication |
0.6% |
|
| Transplant Rejection |
21.4% |
| Sepsis |
9.1% |
| Residual Urine |
8.6% |
| Urinary Tract Infection |
8.6% |
| Pyrexia |
5.3% |
| Renal Impairment |
4.3% |
| Cytomegalovirus Infection |
3.7% |
| Small Intestinal Obstruction |
3.7% |
| Systemic Candida |
3.7% |
| Bone Marrow Oedema |
3.2% |
| Pneumonia |
3.2% |
| Respiratory Failure |
3.2% |
| Wound Dehiscence |
3.2% |
| Bacterial Infection |
2.7% |
| Pain |
2.7% |
| Polyomavirus-associated Nephropathy |
2.7% |
| Renal Failure |
2.7% |
| Renal Failure Chronic |
2.7% |
| Reversible Posterior Leukoencephalopathy Syndrome |
2.7% |
| Thrombocytopenia |
2.7% |
|
| Concomitant |
| Renal Transplant |
19.5% |
| Immunosuppression |
19.3% |
| Prophylaxis Against Transplant Rejection |
16.6% |
| Immunosuppressant Drug Therapy |
9.3% |
| Product Used For Unknown Indication |
7.5% |
| Prophylaxis |
5.1% |
| Liver Transplant |
3.4% |
| Infection Prophylaxis |
3.0% |
| Prophylaxis Against Graft Versus Host Disease |
2.2% |
| Transplant |
1.9% |
| Hypertension |
1.7% |
| Kidney Transplant Rejection |
1.6% |
| Lung Transplant |
1.5% |
| Organ Transplant |
1.2% |
| Premedication |
1.2% |
| Drug Use For Unknown Indication |
1.2% |
| Renal And Liver Transplant |
1.0% |
| Transplant Rejection |
1.0% |
| Bronchopulmonary Aspergillosis |
0.9% |
| Intestinal Transplant |
0.9% |
|
| Transplant Rejection |
9.4% |
| Death |
7.2% |
| Ventricular Tachycardia |
7.2% |
| Food Allergy |
5.8% |
| Idiopathic Thrombocytopenic Purpura |
5.8% |
| Focal Segmental Glomerulosclerosis |
5.1% |
| Multi-organ Failure |
5.1% |
| Post Transplant Lymphoproliferative Disorder |
5.1% |
| Proteinuria |
5.1% |
| Kidney Transplant Rejection |
4.3% |
| Pyrexia |
4.3% |
| Renal Failure Acute |
4.3% |
| Renal Impairment |
4.3% |
| Urinary Tract Infection |
4.3% |
| White Blood Cell Count Decreased |
4.3% |
| Cytomegalovirus Infection |
3.6% |
| Fall |
3.6% |
| Nephropathy Toxic |
3.6% |
| Pleural Effusion |
3.6% |
| Pneumonia |
3.6% |
|
| Interacting |
| Immunosuppression |
25.9% |
| Product Used For Unknown Indication |
22.2% |
| Renal Transplant |
18.5% |
| Thrombosis Prophylaxis |
14.8% |
| Hypertension |
11.1% |
| Liver Transplant |
7.4% |
|
| Vomiting |
40.0% |
| Drug Interaction |
20.0% |
| Duodenal Ulcer |
20.0% |
| Immunosuppressant Drug Level Increased |
20.0% |
|
